Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

BACKGROUND: Thirteen-valent pneumococcal conjugate vaccine (PCV13) and 10-valent pneumococcal conjugate vaccine (PCV10) are two recently approved vaccines for the active immunization against Streptococcus pneumoniae causing invasive pneumococcal disease in infants and children. PCV13 offers broader...

Descripción completa

Detalles Bibliográficos
Autores principales: Earnshaw, Stephanie R, McDade, Cheryl L, Zanotti, Giovanni, Farkouh, Raymond A, Strutton, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532329/
https://www.ncbi.nlm.nih.gov/pubmed/22530841
http://dx.doi.org/10.1186/1471-2334-12-101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532329/
https://www.ncbi.nlm.nih.gov/pubmed/22530841
http://dx.doi.org/10.1186/1471-2334-12-101

Ejemplares similares